Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03462342 |
Title | Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer (CAPRI) |
Acronym | CAPRI |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Pennsylvania |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |